Drug name - Prezcobix

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

US8148374 JANSSEN PRODS Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

CN101796040A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN101679325B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103275033B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B JANSSEN PRODS Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN101679325A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN332719B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3112355A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487161B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518987

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Aug, 2024

(1 year, 10 months from now)

US7700645

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Jun, 2027

(4 years from now)

US10039718 JANSSEN PRODS Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

More Information on Dosage
Strength Dosage Availability
150MG;800MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.